therapeutics

Q&A: The status of the Access to Prescription Digital Therapeutics Act

Q&A: The status of the Access to Prescription Digital Therapeutics Act

The Access to Prescription Digital Therapeutics Act, initially introduced in the U.S. Senate in 2022 and reintroduced in March of this year, aims to amend the Social Security Act to provide Medicare and Medicaid coverage and reimbursement for prescription digital therapeutics.  Jennifer Mathieu, senior vice president of professional and government affairs at the Academy of […]

Q&A: The status of the Access to Prescription Digital Therapeutics Act Read More »

h2o Therapeutics, AmerisourceBergen partner on Parkinson’s disease app

h2o Therapeutics, AmerisourceBergen partner on Parkinson’s disease app

h2o Therapeutics, a digital health company that develops AI, augmented reality and mobile-based therapeutics, is partnering with global healthcare company AmerisourceBergen to commercialize its Parkinson’s disease-focused offering dubbed Parky. Parky, which received 510(k) clearance last year, is a prescription mobile app that utilizes the Apple Watch to monitor an individual’s Parkinson’s disease symptoms, such as

h2o Therapeutics, AmerisourceBergen partner on Parkinson’s disease app Read More »

Adoption of digital therapeutics will require flexibility and patience

Adoption of digital therapeutics will require flexibility and patience

CHICAGO — During the Venture Connect panel on demystifying digital therapeutics at the 2023 HIMSS Global Health Conference & Exhibition here on Tuesday, panelists provided insights into the state of investments in digital therapeutics, the barriers to adoption, challenging existing standards of care and how success in the sector requires patience and persistence.  “Very recently

Adoption of digital therapeutics will require flexibility and patience Read More »

Shopping Cart